Skip to content
PeptideRank
Ivim Health logo

Provider review

Ivim Health cost: $133/mo + $74.99/mo membership tirzepatide

A $74.99/mo membership the headline omits — and a quiz price that contradicts it.

The $133/mo compounded-tirzepatide headline omits a separately required $74.99/mo membership (disclosed only in small print on that same page). Independently, Ivim's own live qualification-quiz configuration discloses "Compounded GLP-1 Options starting at $249/month," payable upfront, for what its site calls the same product category — a contradiction Ivim has with itself, not a promo-versus-standing-rate gap that resolves on a closer read.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

1 of 4 disclosed openly

What Ivim Health discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit Ivim Health

Pharmacy

Not categorized

Labs

Not stated

States

Not published

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not confirmed

The catch — Two stacked mechanisms, both sourced to Ivim's own pages: (1) a $74.99/mo membership required before any medication ships, not mentioned in the $133/mo tirzepatide headline itself; (2) medication is sold in prepaid multi-month "Program" terms (Ivim's own Terms and Conditions, §§16 and 29, name "four- or six-month programs"), and its own live qualification quiz discloses a $249/month price for the same product category that "must be paid upfront" — a different billing structure than the recurring-sounding $133/mo headline.

See plans at Ivim Health

Prices read from Ivim Health's own site · August 2026

What they advertise

Compounded tirzepatide: Ivim's own compounded tirzepatide page headlines "Starting at $133/mo," with a footnote elsewhere on the same page stating, "Medical programs require an Ivím membership at $74.99/month." Compounded semaglutide: its own compounded semaglutide page headlines "Starting at $149/mo," with the identical $74.99/month membership requirement disclosed on that same page. Sermorelin: its own sermorelin page headlines "$129 + $75/mo Membership" directly beside the price — a more transparent disclosure than either GLP-1 page's small-print footnote.

What you actually pay

By the marketing pages' own math: tirzepatide $133 + $74.99 membership = $207.99 combined; semaglutide $149 + $74.99 membership = $223.99 combined; sermorelin $129 + $75 membership = $204 combined. But Ivim's own live qualification-quiz configuration (fetched directly from ivimhealth.com/wp-content/reactpress/apps/forms/public/json/flows/weightloss-quiz.json, step 18) states instead: "Ivím's low cost out-of-pocket Compounded GLP-1 Options starting at $249 / month," with the disclosure "Pricing is per month and must be paid upfront. $74.99/mo membership is also required." That is a materially higher, differently-billed figure ($249 prepaid + $74.99/mo = $323.99 combined) for what Ivim's own site calls the same product category — covering both tirzepatide and semaglutide alike, since the quiz disclosure doesn't distinguish between them — a contradiction Ivim has with itself, and one it does not settle anywhere short of an actual medical intake.

Money you will meet later

  • Early cancellation of the medication program triggers a $100 administrative/restocking fee per undeveloped 3-month portion, or $50 per undeveloped 2-month portion (Ivim's own Terms and Conditions §16) — waived only if a provider determines the member is medically ineligible to continue.
  • All dispensed or prescribed medication is non-refundable regardless of usage or cancellation, per Ivim's own Refund and Returns Policy.
  • The $74.99/mo membership itself "cannot be canceled mid-term," per Ivim's own Membership Agreement §2.4 — the member remains "contractually obligated to pay all remaining fees for the full duration of the program selected," separate from the medication restocking fee above.

The bottom line

Ivim Services LLC dba Ivim (a real company, BBB-accredited since 2/28/2023, A+ rating, business start date 4/29/2022, with two named founders and a named Chief Medical Officer on its own About page) is a live, operating telehealth company selling compounded tirzepatide, a sublingual sermorelin product, compounded liraglutide, branded GLP-1 referrals, and a long tail of supplements. Nothing here rises to what got MEDVi excluded from this site outright — documented deepfaked patient photos and fabricated physician personas. No independent journalism names Ivim. The single "lawsuit" page that surfaces in search (lawfold.com) is a template mass-tort marketing page with no docket, no court and no named plaintiff, which is advertising rather than litigation; the one genuine court record is Ivim's own amicus brief supporting the compounding industry against FDA restrictions. What does remain is three things: an FDA warning letter (MARCS-CMS 721816, February 20, 2026) over a mislabeled-compounder claim, a contradiction across Ivim's own legal documents about which state has jurisdiction over it, and a pricing structure that doesn't match its own $133/mo headline — a mandatory $74.99/mo membership stacked underneath it, medication sold in prepaid multi-month "Program" terms with an early-cancellation restocking fee, and a live quiz disclosure of $249/month (paid upfront) for the same product category the marketing page prices at $133/mo.

Ivim Health appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You've read Ivim's FDA warning letter and are satisfied it's a single, disclosable mislabeled-compounder citation (the same shape as Strut Health's and BluefitMD's letters already here) rather than a documented fraud pattern.
  • You want a checkable trust badge that actually checks out — Ivim's own LegitScript seal (ID 16392114) resolves at LegitScript's own registry, unlike BluefitMD's, which fails the identical check.
  • You're comfortable with a membership-gated telehealth model and will read the small print for the required $74.99/mo fee before signing up, rather than budgeting off the $133/mo headline alone.

Look elsewhere if

  • You're budgeting off Ivim's own "Starting at $133/mo" headline — its own qualification quiz separately discloses $249/month, paid upfront, for the same "Compounded GLP-1 Options" category, and a mandatory $74.99/mo membership applies either way.
  • A provider whose own legal documents agree on where the company is even registered matters to you — Ivim's Terms name Michigan as both its registered state and its governing law, then name Ohio as the venue for disputes and arbitration in the very same document.
  • You want to cancel mid-program — Ivim's own Membership Agreement states membership "cannot be canceled mid-term," and early cancellation of the medication program itself triggers a $100 or $50 restocking fee per undeveloped portion.

What Ivim Health offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

Ivim Health does not name the pharmacy that fills your prescription.

What its own site says

Unknown category. Ivim's own compounded tirzepatide page states only, "Ivím only selects FDA-inspected, state-regulated compounding pharmacies that meet regulatory board standards for quality and safety" — neither "503A" nor "503B" appears anywhere checked (product pages, Terms and Conditions, Refund and Returns Policy, Membership Agreement, Privacy Policy, or HIPAA Notice), and no specific pharmacy is named by name anywhere.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not published

Not published. No state list and no "all 50 states" claim appears anywhere on the site's public pages (product pages, Terms and Conditions, Membership Agreement, Refund and Returns Policy, Privacy Policy, or HIPAA Notice) — a reader only reaches a location field after completing Ivim's full medical questionnaire.

The honest cons

The part they would rather you skipped

FDA issued Ivim a warning letter (MARCS-CMS 721816, February 20, 2026, Center for Drug Evaluation and Research), addressed to Ivim Services LLC dba Ivim at 4200 Regent Street, Suite 200, Columbus, OH 43219 — the identical address confirmed as Ivim's own BBB profile address (A+ rating, accredited since 2/28/2023). The letter states FDA reviewed ivimhealth.com in December 2025 and found the compounded semaglutide and tirzepatide products displayed on the site identify "Ivim" on the pictured label, "suggesting Ivim is the compounder of those drugs when in fact it is not" — misbranded under FDCA §§502(a) and 502(bb), the same single-issue template as the first of BluefitMD's two citations on this same roster, and the same disclosable-not-disqualifying shape as Strut Health's letter. Independent of the FDA letter, Ivim's own legal documents contradict each other about which state even has jurisdiction over the company: its Terms and Conditions states it is "registered in Michigan... registered office at 336 W 1st St Ste 113, Flint, MI 48502" and that the Terms are "governed by... the laws of the State of Michigan" (§18) — then, in the same document, states disputes are subject to "exclusive jurisdiction and venue in the state and federal courts located in Franklin County, Ohio" (Columbus, where the FDA letter and BBB profile both place it) and that arbitration "will be conducted in Franklin County, Ohio." Its separate Membership Agreement states Michigan law AND Michigan jurisdiction, but directs legal notices to "Ivim's Principal Mailing Address at 4200 Regent Street, Suite 200, Columbus, OH 43219" — the Ohio address. Three of Ivim's own documents name three different combinations of state and address for what is legally the same company.

  • FDA warning letter (MARCS-CMS 721816, Feb 20, 2026) over a mislabeled-compounder claim — see this review's knock for the full, independently-verified finding.
  • A real self-contradiction across Ivim's own legal documents about which state has jurisdiction: Michigan (Terms' registered office and governing law; Membership Agreement's governing law and venue) versus Ohio (Terms' own dispute venue and arbitration location; Membership Agreement's own mailing address for legal notices).
  • The $133/mo compounded-tirzepatide headline omits a mandatory $74.99/mo membership, disclosed only in small print on the same page — combined, $207.99 by the marketing page's own math.
  • Ivim's own live qualification-quiz configuration discloses a materially different $249/month price (paid upfront, not monthly) for the same "Compounded GLP-1 Options" category the tirzepatide page separately headlines at $133/mo — a first-party contradiction this review could not resolve.
  • Medication is sold in prepaid multi-month "Program" terms; canceling early triggers a $100 or $50 restocking fee per undeveloped portion, and all dispensed medication is non-refundable regardless of cancellation.
  • The $74.99/mo membership itself cannot be canceled mid-term, per Ivim's own Membership Agreement.
  • No pharmacy is named by name anywhere on the site — only a vague "FDA-inspected, state-regulated compounding pharmacies" category claim, weaker than several peers here that state a specific 503A/503B category.
  • No state coverage list or "all 50 states" claim is published anywhere; availability is something a reader only learns after completing a full medical questionnaire.

None of this is unique to Ivim Health — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Ready to get started?

Prices and plans in this category change often — check Ivim Health's current pricing before you decide. Ours was read from their own site in August 2026.

See Ivim Health pricing

Facts on this page reflect Ivim Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Ivim Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.

Ivim Health

4 compounds from $129/mo + $75/mo membership

Visit